Baidu
map

贵州省中医药工作会召开:完善中医药发展政策措施和保障机制

2018-04-20 黄 岚 中国中医

2018年贵州省中医药工作会议4月16日在贵阳市召开。会议提出将完善中医药发展政策措施和保障机制,深入贯彻落实中医药法,加快制定《贵州省中医医术确有专长人员的考核注册管理实施细则》。

2018年贵州省中医药工作会议4月16日在贵阳市召开。会议提出将完善中医药发展政策措施和保障机制,深入贯彻落实中医药法,加快制定《贵州省中医医术确有专长人员的考核注册管理实施细则》。

会议研究部署了2018年贵州省中医药工作任务,强调要进一步完善中医药发展政策措施和保障机制,重点开展中医药法的学习贯彻工作,加快制定《贵州省中医医术确有专长人员的考核注册管理实施细则》;推进公立中医医院改革,建立现代医院管理制度,探索医保支付方式改革工作,推动相关部门研究制定中医药按病种付费等政策;提升中医药产业现代化水平,实现中药民族药工业总产值突破500亿元,中药材种植及保护抚育总面积达到700万亩以上,使中医药产业成为全省国民经济重要支柱之一。

会议明确,将发展有中医药特色和优势的中医医疗机构,力争每个县至少有1个公立中医医院,新建22个省级中医重点专科,加强基层医疗机构中医诊疗区(中医馆)建设和省级基层卫生机构中医诊疗区健康信息平台建设,进一步提升基层中医药服务能力。

会议对党的十八以来贵州省中医药改革发展的成绩进行了回顾总结。五年来,该省中医药服务能力显着提升,共投入19亿元经费对61家中医院进行了改扩建,全省中医总诊疗量从506万人次增加到901万人次,89.29%的乡镇卫生院、90.42%的社区卫生服务中心、72.24%的社区卫生服务站、59.03%的村卫生室可提供中医药服务。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1993402, encodeId=68971993402ce, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sun Mar 17 19:34:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933009, encodeId=7a19193300907, content=<a href='/topic/show?id=bdad5e48757' target=_blank style='color:#2F92EE;'>#政策措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57487, encryptionId=bdad5e48757, topicName=政策措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Jun 07 03:34:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956191, encodeId=4a2f19561911c, content=<a href='/topic/show?id=6b77924894e' target=_blank style='color:#2F92EE;'>#贵州省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92489, encryptionId=6b77924894e, topicName=贵州省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Apr 22 02:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260328, encodeId=fae412603286a, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 22 08:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409494, encodeId=317b1409494bc, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Apr 22 08:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1993402, encodeId=68971993402ce, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sun Mar 17 19:34:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933009, encodeId=7a19193300907, content=<a href='/topic/show?id=bdad5e48757' target=_blank style='color:#2F92EE;'>#政策措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57487, encryptionId=bdad5e48757, topicName=政策措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Jun 07 03:34:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956191, encodeId=4a2f19561911c, content=<a href='/topic/show?id=6b77924894e' target=_blank style='color:#2F92EE;'>#贵州省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92489, encryptionId=6b77924894e, topicName=贵州省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Apr 22 02:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260328, encodeId=fae412603286a, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 22 08:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409494, encodeId=317b1409494bc, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Apr 22 08:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1993402, encodeId=68971993402ce, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sun Mar 17 19:34:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933009, encodeId=7a19193300907, content=<a href='/topic/show?id=bdad5e48757' target=_blank style='color:#2F92EE;'>#政策措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57487, encryptionId=bdad5e48757, topicName=政策措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Jun 07 03:34:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956191, encodeId=4a2f19561911c, content=<a href='/topic/show?id=6b77924894e' target=_blank style='color:#2F92EE;'>#贵州省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92489, encryptionId=6b77924894e, topicName=贵州省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Apr 22 02:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260328, encodeId=fae412603286a, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 22 08:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409494, encodeId=317b1409494bc, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Apr 22 08:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1993402, encodeId=68971993402ce, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sun Mar 17 19:34:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933009, encodeId=7a19193300907, content=<a href='/topic/show?id=bdad5e48757' target=_blank style='color:#2F92EE;'>#政策措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57487, encryptionId=bdad5e48757, topicName=政策措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Jun 07 03:34:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956191, encodeId=4a2f19561911c, content=<a href='/topic/show?id=6b77924894e' target=_blank style='color:#2F92EE;'>#贵州省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92489, encryptionId=6b77924894e, topicName=贵州省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Apr 22 02:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260328, encodeId=fae412603286a, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 22 08:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409494, encodeId=317b1409494bc, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Apr 22 08:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=)]
    2018-04-22 bioon3
  5. [GetPortalCommentsPageByObjectIdResponse(id=1993402, encodeId=68971993402ce, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sun Mar 17 19:34:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933009, encodeId=7a19193300907, content=<a href='/topic/show?id=bdad5e48757' target=_blank style='color:#2F92EE;'>#政策措施#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57487, encryptionId=bdad5e48757, topicName=政策措施)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Jun 07 03:34:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956191, encodeId=4a2f19561911c, content=<a href='/topic/show?id=6b77924894e' target=_blank style='color:#2F92EE;'>#贵州省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92489, encryptionId=6b77924894e, topicName=贵州省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Apr 22 02:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260328, encodeId=fae412603286a, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 22 08:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409494, encodeId=317b1409494bc, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Apr 22 08:34:00 CST 2018, time=2018-04-22, status=1, ipAttribution=)]
    2018-04-22 cathymary

相关资讯

贵州省率先实现乡镇卫生院远程医疗全覆盖

“李医生,我最近血压平稳多了。”“你气色看起来不错,不舒服了及时视频连线我……”这是记者在贵州省遵义市新蒲新区沙滩村采访时,69岁的姜兴贵在家中通过电视上的远程医疗平台与近十公里外镇卫生院里的医生复诊的画面。如今,在贵州越来越多的人们同姜兴贵一样,在家门口就可以享受上级大医院、大专家的诊疗服务。12月25日,记者在贵州省政府新闻办召开的新闻发布会上获悉,目前,贵州省已全面完成乡镇卫生院(政府办社区

Baidu
map
Baidu
map
Baidu
map